Delivery Order SPE2DB25D7056-SPE2DB25FTMZN
Award Date 8/15/25
Potential Completion Date 8/18/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $8,330.29 delivery order to AmerisourceBergen Drug Corp for Loryna 3 mg-0.02 mg tablets (28-count packaging) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be performed from the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) with a ceiling value of $5,258.67. This firm fixed-price delivery order, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28-count packaging) valued at $1,875.80. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vehicle running through December 2026. The order will be fulfilled from the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Loryna 3 mg-0.02 mg tablets (28 count) with a firm fixed price ceiling value of $1,049.59. This is a competitive award with no set-aside designation, executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle that extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Loryna 3 mg-0.02 mg tablets (28-count) with a ceiling value of $1,004.30. This competitively awarded, firm fixed-price contract, issued on September 2, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packages) under a firm fixed-price contract with a ceiling value of $5,381.36. The order was competitively awarded without set-aside provisions and is scheduled for completion by September 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Loryna 3 mg-0.02 mg tablets in quantities of 28 with a ceiling value of $9,337.76. This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, represents a competitively awarded non-set-aside contract executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $3,879.93 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Loryna 3-0.02mg contraceptive medication (84 tablets). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract vehicle. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $3,963.54 to AmerisourceBergen Drug Corp for the supply of Loryna 3 mg-0.02 mg tablets (28-count packages) with a completion date of September 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $1 billion ceiling value and extends through December 2026. The pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,762.17, is for the delivery of Loryna 3 mg-0.02 mg tablets. The award has an ultimate completion date of May 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...